BLINCYTO (Blinatumomab) for injection 35 mcg/vial

Complete Wellness

Category: Drug Info Available

For more information, visit our official website at farmakopedia.com

Visit Official Site Contact Us

Description

Manufacturer
Amgen Biopharmaceuticals Malaysia Sdn Bhd

Contents
Blinatumomab

Indication
Minimal residual disease (MRD) positive, relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Drug interaction
Monitor for toxicity (eg, warfarin) or drug conc (eg, cyclosporine) w/ CYP450 substrates.

More detail about Complete Wellness

Complete Wellness General Health | Healthy Lifestyle | Drug & Supplement Information Provider ~Complete Wellness

Malaysia